O-Galactoside 8e.30 This compound has been previously
reported30 but no analytical data were given. Glycosidation of
3,4,6-tri-O-acetyl-D-galactal (200 mg, 0.735 mmol) with 4-meth-
oxyphenol (109 mg, 1.2 equivalents, 0.882 mmol) and Al(OTf)3
(20 mol%, 69 mg) in DCM (2.0 mL) at 0 °C for 4 hours afforded
glycoside 8e as an inseparable α/β (>19 : 1) mixture in a com-
bined yield of 186 mg (64%) as a cream solid. Found C, 57.9;
H, 6.3%. C19H24O9 requires C, 57.6; H, 6.1%; Mp 60–62 °C;
116.4, 95.7, 67.4, 66.4, 65.9, 62.0, 30.1, 20.8, 20.6, 20.5; IR
νmax/cm−1 2962, 1740, 1490, 1226, 1016, 798; HR-CIMS calc
for C18H23O8 367.1393 [M + H]+, found 367.1374, calc for
C16H20O6 [M–C2H3O2]+ 307.1182, found 307.1129.
O-Galactoside 8b. Glycosidation of 3,4,6-tri-O-acetyl-D-galac-
tal (200 mg, 0.735 mmol) with 4-bromophenol (152 mg, 1.2
equivalents, 0.882 mmol) and Al(OTf)3 (20 mol%, 69 mg) in
DCM (2.0 mL) at 0 °C for 6 hours afforded glycoside 8b as an
inseparable α/β (18 : 1) mixture in a combined yield of 249 mg
(76%) as a cream solid. Found C, 48.2; H, 5.0%. C18H21BrO8
requires C, 48.6; H, 4.8%; Rf = 0.44 (3 : 1, hexane–EtOAc);
1H NMR (400 MHz, CDCl3): δH 7.35 (d, 2H, J 8.4 Hz), 6.92 (d,
2H, J 8.4 Hz), 5.66 (br s, 1H), 5.43 (d, 1H, J 12.0 Hz), 5.35 (br
s, 1H), 4.17 (t, 1H, J 6.4 Hz), 4.04–4.00 (m, 2H), 2.22 (br t, 1H,
J 12.4 Hz), 2.12 (s, 3H), 2.06 (dd, 1H, J 12.8, 5.2 Hz), 1.98
(s, 3H), 1.89 (s, 3H); 13C NMR (75 MHz, CDCl3): δC 170.3,
170.1, 170.0, 155.3, 132.3, 118.2, 114.7, 95.9, 67.6, 66.3, 65.8,
62.0, 30.0, 20.8, 20.6, 20.5; IR νmax/cm−1 2960, 1743, 1487,
1367, 1221, 1198, 1115, 1018, 823; HR-CIMS calc for
C18H21BrO8 444.0420, 446.0399 [M]+, found 444.0418,
446.0292, calc for C16H18BrO6 [M–C2H3O2]+ 385.0287,
387.0266, found 385.0284, 387, 0269.
1
Rf = 0.40 (3 : 1, hexane–EtOAc); H NMR (400 MHz, CDCl3):
δH 6.96 (d, 2H, J 9.2 Hz), 6.78 (d, 2H, J 8.8 Hz), 5.59 (d, 1H,
J 2.8 Hz), 5.48–5.43 (m, 1H), 5.36 (d, 1H, J 2.8 Hz), 4.26 (t,
1H, J 6.6 Hz), 4.07–4.03 (m, 2H), 3.73 (s, 3H), 2.20 (td, 1H,
J 9.5, 2.7 Hz), 2.12 (s, 3H), 2.06 (dd, 1H, J 9.6, 5.2 Hz), 1.98 (s,
3H), 1.91 (s, 3H); 13C NMR (75 MHz, CDCl3): δC 170.4, 170.2,
170.0, 154.9, 150.2, 117.7, 114.4, 96.5, 67.3, 66.4, 66.0, 62.1,
55.5, 30.2, 20.8, 20.7, 20.6; IR νmax/cm−1 2944, 1730, 1497,
1245, 1204, 1011, 975; HR-CIMS calc for C19H24O9
[M–C2H3O2]+ 337, 1287, found 337.1315.
O-Galactoside 8f.30 This compound has been previously
reported30 but no analytical data were given. Glycosidation of
3,4,6-tri-O-acetyl-D-galactal (200 mg, 0.735 mmol) with p-cresol
(95 mg, 1.2 equivalents, 0.882 mmol) and Al(OTf)3 (20 mol%,
69 mg) in DCM (2.0 mL) at 0 °C for 4 hours afforded glycoside
8f as an inseparable α/β (>19 : 1) mixture in a combined yield of
198 mg (71%) as a light yellow oil. Found C, 59.8; H, 6.2%.
C19H24O8 requires C, 60.0; H, 6.4%; Rf = 0.46 (3 : 1, hexane–
O-Galactoside 8c. Glycosidation of 3,4,6-tri-O-acetyl-D-galac-
tal (200 mg, 0.735 mmol) with 4-iodophenol (194 mg, 1.2
equivalents, 0.882 mmol) and Al(OTf)3 (20 mol%, 69 mg) in
DCM (2.0 mL) at 0 °C for 6 hours afforded glycoside 8c as an
inseparable α/β (11 : 1) mixture in a combined yield of 264 mg
(73%) as a cream solid. Found C, 43.7; H, 4.1%. C18H21IO8
requires C, 43.9; H, 4.3%; Mp 62–64 °C; Rf = 0.45 (3 : 1,
1
EtOAc); H NMR (400 MHz, CDCl3): δH 7.05 (d, 2H, J 8.0
Hz), 6.92 (d, 2H, J 7.6 Hz), 5.65 (s, 1H), 5.46 (m, 1H), 5.36 (s,
1H), 4.24 (t, 1H, J 6.6 Hz), 4.08–4.01 (m, 2H), 2.26 (s, 3H),
2.19 (d, 1H, J 12.4 Hz), 2.12 (s, 3H), 2.06 (dd, 1H, J 9.4, 4.6
Hz), 1.99 (s, 3H), 1.90 (s, 3H); 13C NMR (75 MHz, CDCl3):
δC 170.3, 170.2, 170.0, 154.1, 131.6, 129.8, 116.4, 96.0, 67.3,
66.4, 66.0, 62.0, 30.2, 20.8, 20.6, 20.5, 20.4; IR νmax/cm−1
2961, 1742, 1509, 1220, 1037, 1018, 785; HR-CIMS calc for
C17H21O6 [M–C2H3O2]+ 321.1338, found 321.1271.
1
hexane–EtOAc); H NMR (400 MHz, CDCl3): δH 7.52 (d, 2H,
J 7.6 Hz), 6.80 (d, 2H, J 8.0 Hz), 5.66 (br s, 1H), 5.42 (d, 1H,
J 12.4 Hz), 5.34 (s, 1H), 4.16 (t, 1H, J 6.4 Hz), 4.06–3.96 (m,
2H), 2.21 (br t, 1H, J 12.0 Hz), 2.11 (s, 3H), 2.05 (dd, 1H, J 9.8,
5.0 Hz), 1.98 (s, 3H), 1.89 (s, 3H); 13C NMR (75 MHz, CDCl3):
δC 170.2, 170.1, 169.9, 156.0, 138.2, 118.7, 95.8, 84.9, 67.6,
66.2, 65.7, 61.9, 30.0, 20.8, 20.6, 20.5; IR νmax/cm−1 2955,
1744, 1483, 1369, 1221, 1114, 1021, 820, 731; HR-CIMS calc
for C16H18IO6 [M–C2H3O2]+ 433.0148, found 433.0251.
Synthesis of symmetrical glucoside bolaform 10
Tri-O-acetyl-D-glucal (400 mg, 1.470 mmol) was stirred in DCM
(5 mL) with the diol (0.5 equivalents, 0.735 mmol) and Al
(OTf)3 (5 mol%, 17 mg) at room temperature. After completion
of the reaction as traced by TLC (2 h), the reaction was quenched
by adding concentrated sodium bicarbonate (4 mL) solution and
the mixture extracted with CH2Cl2 (3 × 5 mL). The combined
organic phases were dried over anhydrous magnesium sulfate.
The volatile component was removed under vacuum leaving the
crude product that was subjected to column chromatography on
flash silica for purification, using neat ethyl acetate as eluent.
The pure product was obtained in a yield of 87% (444 mg).
Found C, 56.2; H, 6.2%. C24H30O12 requires C, 56.5;
H, 5.9%; Mp: 90–92 °C; Rf = 0.67 (ethyl acetate); 1H NMR
(300 MHz, CDCl3): δH 5.83 (d, 2H, J 10.4 Hz), 5.77 (dt, 2H,
J 10.2, 2.4 Hz), 5.29–5.22 (m, 2H), 5.14 (s, 2H), 4.36–3.96
(m, 10H), 2.03 (d, 12H, J 4.5 Hz); 13C NMR (75 MHz, CDCl3):
δC 170.6, 170.1, 129.6, 127.1, 92.5, 81.9, 67.0, 65.0, 62.6, 55.1,
20.8, 20.6; IR νmax/cm−1 2923, 1727, 1374, 1230, 1187, 1031,
957; MS: No useful peaks were identified from the CIMS
O-Galactoside 8d. Glycosidation of 3,4,6-tri-O-acetyl-D-galac-
tal (200 mg, 0.735 mmol) with 2-iodophenol (194 mg, 1.2
equivalents, 0.882 mmol) and Al(OTf)3 (20 mol%, 69 mg) in
DCM (2.0 mL) at 0 °C for 7 hours afforded glycoside 8d as an
inseparable α/β (>19 : 1) mixture in a combined yield of 239 mg
(66%) as a cream solid. Found C, 43.9; H, 4.4%. C18H21IO8
requires C, 43.9; H, 4.3%; Mp 80–82 °C; Rf = 0.44 (3 : 1,
1
hexane–EtOAc); H NMR (400 MHz, CDCl3): δH 7.70 (d, 1H,
J 8.0 Hz), 7.20 (t, 1H, J 7.6 Hz), 7.03 (d, 1H, J 8.4 Hz), 6.71
(t, 1H, J 7.6 Hz), 5.70 (br s, 1H), 5.55–5.50 (m, 1H), 5.37 (br s,
1H), 4.18 (t, 1H, J 6.6 Hz), 3.99 (d, 2H, J 6.6 Hz), 2.24–2.14
(m, 2H), 2.08 (s, 3H), 1.95 (s, 3H), 1.85 (s, 3H); 13C NMR
(75 MHz, CDCl3): δC 170.2, 170.0, 169.8, 154.8, 139.3, 129.2,
124.1, 115.3, 96.4, 87.5, 68.0, 66.3, 65.9, 61.9, 30.0, 20.7, 20.6,
20.5; IR νmax/cm−1 2963, 1730, 1472, 1224, 1197, 1018, 799;
HR-CIMS calc for C16H18IO6 [M–C2H3O2]+ 433.0148, found
433.0060.
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 5636–5642 | 5641